Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cardiovascular

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1533896

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1533896

Amlodipine Besylate

PUBLISHED:
PAGES: 177 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

Global Amlodipine Besylate Market to Reach US$1.3 Billion by 2030

The global market for Amlodipine Besylate estimated at US$1.2 Billion in the year 2023, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 2.1% over the analysis period 2023-2030. High Blood Pressure Application, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$599.8 Million by the end of the analysis period. Growth in the Heart Disease Application segment is estimated at 2.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$314.6 Million While China is Forecast to Grow at 4.3% CAGR

The Amlodipine Besylate market in the U.S. is estimated at US$314.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$261.3 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.5% and 1.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.0% CAGR.

Global Amlodipine Besylate Market - Key Drivers and Trends Summarized

Amlodipine is a calcium channel blocker medication primarily used to treat high blood pressure (hypertension) and angina (chest pain). By inhibiting the influx of calcium ions into cardiac and smooth muscle cells, amlodipine helps relax and widen blood vessels, improving blood flow and reducing the heart's workload. This mechanism of action makes it an effective treatment for preventing strokes, heart attacks, and other cardiovascular issues associated with hypertension. Available in various dosages, amlodipine is often prescribed as a once-daily oral tablet and can be used alone or in combination with other antihypertensive agents.

The use of amlodipine has expanded significantly since its introduction, with numerous studies validating its efficacy and safety. It is now one of the most commonly prescribed medications for managing hypertension globally. The drug's popularity is partly due to its relatively mild side effect profile compared to other antihypertensives, making it suitable for long-term use. Moreover, the versatility of amlodipine, both as a monotherapy and in combination with other medications like ACE inhibitors or diuretics, has enhanced its utility in clinical practice. The development of generic versions of amlodipine has also made it more accessible and affordable, contributing to its widespread adoption. In addition to treating hypertension and angina, ongoing research is exploring potential new indications for amlodipine, such as its role in managing coronary artery disease and other cardiovascular conditions.

The growth in the amlodipine market is driven by several factors. Firstly, the increasing prevalence of hypertension and cardiovascular diseases worldwide has significantly boosted the demand for effective antihypertensive medications. Secondly, the aging global population, which is more prone to hypertension and related disorders, has further escalated the need for treatments like amlodipine. Additionally, the continuous advancement in pharmaceutical research has led to the development of improved formulations and combination therapies that enhance patient compliance and therapeutic outcomes. The expansion of healthcare infrastructure in emerging markets has also improved access to hypertension treatments, thereby driving market growth. Furthermore, strategic marketing efforts and educational initiatives by pharmaceutical companies have raised awareness about hypertension management, encouraging more patients to seek treatment. Finally, favorable regulatory environments and the increasing availability of generic versions have made amlodipine more accessible, contributing to its sustained market growth.

Select Competitors (Total 36 Featured) -

  • Amsal Chem Pvt. Ltd.
  • Apotex Inc.
  • Cadila Pharmaceuticals Ltd.
  • Century Pharmaceuticals Ltd.
  • Changzhou Yabang Pharmaceutical Co. Ltd.
  • Cipla Ltd
  • Dr. Reddys Laboratories Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Midas Pharma GmbH
  • MOEHS IBERICA SL
  • Orbion Pharmaceuticals Pvt. Ltd.
  • Pfizer Inc.
  • Strides Pharma Science Ltd
  • Teva Pharmaceutical USA, Inc.
  • Zydus Pharmaceuticals, Inc.;
Show more
Product Code: MCP26609

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Amlodipine Besylate - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Hypertension and Cardiovascular Diseases Drives Demand for Amlodipine Besylate
    • Advancements in Drug Formulation Enhance Efficacy and Patient Compliance
    • Increasing Geriatric Population Boosts Market Growth for Amlodipine Besylate
    • Growing Awareness of Hypertension Management Expands Market Opportunities
    • Development of Combination Therapies with Amlodipine Besylate Attracts Consumer Interest
    • Personalized Medicine Trends Create New Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Amlodipine Besylate Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Amlodipine Besylate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for High Blood Pressure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for High Blood Pressure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for High Blood Pressure Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Heart Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Amlodipine Besylate by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Amlodipine Besylate by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Amlodipine Besylate by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Amlodipine Besylate by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!